Glaxosmithkline | GSK - Ebit

Stock Price
54.44
Daily Change
-4.68 -7.92%
Monthly
-8.13%
Yearly
45.44%
Q2 Forecast
53.52

Glaxosmithkline reported GBP2.3B in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
AbbVie USD 5.81B 4.36B Dec/2025
Amgen USD 3.96B 464M Dec/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
Aurora Cannabis CAD -35.79M 8.96M Dec/2025
Bausch Health Companies USD 719M 2M Dec/2025
Bristol-Myers Squibb USD 3.47B 567M Dec/2025
Canopy Growth CAD -12.66M 1.64M Dec/2025
Corcept Therapeutics USD 4.49M 5.73M Dec/2025
Drreddys Laboratories INR 16.37B 3.5B Dec/2025
Eli Lilly USD 8.99B 1.57B Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
Glaxosmithkline GBP 2.3B 1.46B Dec/2025
J&J USD 6.62B 1.51B Mar/2026
Merck USD 6.24B 1.32B Dec/2025
Novartis USD 4.06B 530M Dec/2025
Pacira USD 3.19M 9.96M Dec/2025
Perrigo USD 84.4M 9M Dec/2025
Pfizer USD 4.65B 71M Dec/2025
Phibro Animal Health USD 54.99M 2.36M Dec/2025
Prestige Brands USD 82.49M 2.82M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Sanofi EUR 1.94B 239M Mar/2026
Supernus Pharmaceuticals USD 13.82M 74.01M Dec/2025
Takeda JPY 257.49B 568.56B Dec/2025
Teva Pharmaceutical Industries USD 577M 491M Dec/2025
Zoetis USD 835M 140M Dec/2025